A new approach to treatment-resistant depression
We recognize that there is currently a need for access to rapid and effective therapeutic interventions for patients with Depression. Our approach is based on a comprehensive assessment and therapeutic plan, which integrates pharmacological and non-pharmacological components, grounded in a biopsychosocial model.
Over the past two decades, research into the use of psychedelic drugs in Psychiatry and Mental Health has shown increasing evidence of their efficacy and safety in the treatment of Depression. This approach has emerged as a promising option for those who have not achieved results with conventional treatments.
In our protocol, we use a psychedelic medicine supported by Level 1 Evidence in the Treatment of Depression and recommended by the most recent international guidelines. We are therefore committed to providing an evidence-based therapeutic option to support those seeking new treatment possibilities.
Our experience
Over more than two years of dedicated clinical practice, we have had the opportunity to accompany processes of profound transformation in many of our patients. The intervention we offer has proven to be a powerful catalyst for significant therapeutic changes, allowing the unlocking of deep-rooted emotional patterns and the construction of new ways of being in the world.
These positive results are largely due to the careful integration between the neurobiological effects of the medication used and a supportive psychotherapeutic model, based on human relationship, welcoming the experience and safe exploration of the inner world. The combination of these two axes — pharmacological and psychotherapeutic — has shown remarkable potential in promoting self-knowledge, overcoming resistant depressive states and restoring emotional well-being.
Each journey is unique, but it is through this integrative approach that we have witnessed, with increasing frequency, sustained improvements in quality of life, emotional self-regulation capacity and reconnection with a renewed sense of purpose and connection.
Meet our clinical team
The core team at SOMA consists of two psychiatrists with specialized training and clinical experience in the use of psychedelics for psychiatric disorders. Since 2023, this team has been working together with other mental health professionals from Casa de Saúde de Santa Catarina to ensure that all necessary care is provided during treatment.
What does the treatment consist of?
Understand, step by step, what treatment with a psychedelic drug involves, which has been gathering increasing evidence of efficacy and safety in the treatment of Depression.
We clarify your doubts
Consult our Frequently Asked Questions section to clarify all your doubts about our approach: who it is suitable for, how long the treatment lasts and the main precautions you should take.
Schedule appointment
Treatment only begins after an Assessment Consultation, which serves the purpose of confirming that the inclusion criteria for the treatment are present and that there are no criteria that could contraindicate it.